Insmed to Join the Russell Global(R) and Russell 3000(R) Indexes
June 28, 2013 at 16:30 PM EDT
Insmed Incorporated (NASDAQ: INSM ), ("Insmed" or the "Company"), a biopharmaceutical company focused on developing and commercializing an inhaled anti-infective to treat patients battling serious lung diseases that are often life-threatening, today announced that it was included on the list of companies to join the broad-market Russell Global® and
